TNFRSF4 and neoplasm: This is also supported by a preclinical study reporting that the small molecule TGF-β signaling inhibitor synergizes with anti-OX40 to elicit a potent anti-tumor effect against established tumors41,42, although it did not elucidate the underlying mechanism.